A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance.
Journal Information
Full Title: J Antimicrob Chemother
Abbreviation: J Antimicrob Chemother
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Anti-Infective Agents
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Funding The study was funded through PhD fellowships held at University College London (A.G.) and at the University of Liverpool (A.A.), funding from CIRCB in Yaoundé, and a research grant from Janssen held at the University of Liverpool (MANET TRIAL)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025